nanogp8
-
Official Full Name
Cat.# | Product name | Source (Host) | Species | Tag | Protein Length | Price |
---|---|---|---|---|---|---|
NANOGP8-254H | Recombinant Human Nanog homeobox pseudogene 8, His-tagged | E.coli | Human | His | 1-305 a.a. |
![]() |
NANOGP8-2130HCL | Recombinant Human NANOGP8 cell lysate | Human | Non |
![]() |
Involved Pathway
nanogp8 involved in several pathways and played different roles in them. We selected most pathways nanogp8 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with nanogp8 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|
Protein Function
nanogp8 has several biochemical functions, for example, sequence-specific DNA binding. Some of the functions are cooperated with other proteins, some of the functions could acted by nanogp8 itself. We selected most functions nanogp8 had, and list some proteins which have the same functions with nanogp8. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
sequence-specific DNA binding | OSR2,RORC,MIXL1,VENTX,FOXH1,NR2E1,HIVEP2A,ZIC3,LHX1,FOXO4 |
Interacting Protein
nanogp8 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with nanogp8 here. Most of them are supplied by our site. Hope this information will be useful for your research of nanogp8.
Resources
Related Services
Related Products
References
- Kregel, S; Szmulewitz, RZ; et al. The Pluripotency Factor Nanog Is Directly Upregulated by the Androgen Receptor in Prostate Cancer Cells. PROSTATE 74:1530-1543(2014).
- Mattoo, AR; Zhang, JY; et al. Inhibition of NANOG/NANOGP8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Efficacy of BH3 Mimetics. CLINICAL CANCER RESEARCH 20:5446-5455(2014).